FDA Approves SPIRONOLACTONE — Camber Pharmaceuticals, Inc.

# FDA Approves Spironolactone Generic from Camber Pharmaceuticals Camber Pharmaceuticals, Inc. received FDA approval for its generic spironolactone oral formulation, expanding the competitive landscape for this widely-prescribed potassium-sparing diuretic and anti-androgen medication. The approval is expected to increase price competition and improve patient access to spironolactone, which is used across multiple therapeutic areas including hypertension, heart failure, and dermatology.